The National Comprehensive Cancer Network announces an important new publication and authoritative source of information to guide the selection of appropriate treatment for patients. The first three chapters of the NCCN Drugs & Biologics Compendium(TM) have been recently released and focus on the appropriate use of drugs and biologics in colon, rectal, and anal cancers.
